GlaxoSmithKline Pakistan Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline Pakistan Limited with three other
companies in this sector in Pakistan:
Sanofi Aventis Pakistan Ltd
sales of 12.45 billion Pakistan Rupees [US$100.44 million]
of which 100%
Searle Co Ltd
(13.31 billion Pakistan Rupees [US$107.41 million]
Abbott Laboratories (Pakistan) Ltd
(26.09 billion Pakistan Rupees [US$210.53 million]
of which 75%
During the year ended December of 2017, sales at
GlaxoSmithKline Pakistan Limited were 32.77 billion Pakistan Rupees (US$264.48 million).
increase of 18.9%
versus 2016, when the company's sales were 27.56 billion Pakistan Rupees.